Cargando…
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
Eighteen Caucasian (white, Middle East and Asian) children diagnosed by paediatric rheumatologists in the UK and France as having systemic juvenile idiopathic arthritis (sJIA) were enrolled in this open label, single dose trial. All patients had evidence of continued symptoms and disease activity fo...
Autores principales: | Woo, Patricia, Wilkinson, Nicholas, Prieur, Anne-Marie, Southwood, Taunton, Leone, Valentina, Livermore, Polly, Wythe, Helena, Thomson, David, Kishimoto, Tadamitsu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1297576/ https://www.ncbi.nlm.nih.gov/pubmed/16277681 http://dx.doi.org/10.1186/ar1826 |
Ejemplares similares
-
Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations
por: Green, Katherone L, et al.
Publicado: (2014) -
T-cell activation without proliferation in juvenile idiopathic arthritis
por: Black, Antony PB, et al.
Publicado: (2002) -
An association between the acute phase response and patterns of antigen induced T cell proliferation in juvenile idiopathic arthritis
por: Black, Antony PB, et al.
Publicado: (2003) -
Successful stopping of biologic therapy for remission in children and young people with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2022) -
Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2019)